Volume 108, Issue 2, Pages (January 2002)

Slides:



Advertisements
Similar presentations
Volume 35, Issue 4, Pages (August 2009)
Advertisements

Fabien Darfeuille, Cecilia Unoson, Jörg Vogel, E. Gerhart H. Wagner 
Upregulation of Cortactin Expression During the Maturation of Megakaryocytes by Xi Zhan, Christian C. Haudenschild, Yangson Ni, Elizabeth Smith, and Cai.
Volume 11, Issue 6, Pages (June 2003)
Volume 13, Issue 2, Pages (January 2004)
Volume 32, Issue 6, Pages (December 2008)
Volume 33, Issue 2, Pages (January 2009)
Levels of Polyadenylation Factor CstF-64 Control IgM Heavy Chain mRNA Accumulation and Other Events Associated with B Cell Differentiation  Yoshio Takagaki,
Phosphorylation of NF-κB p65 by PKA Stimulates Transcriptional Activity by Promoting a Novel Bivalent Interaction with the Coactivator CBP/p300  Haihong.
Nicolas Charlet-B, Gopal Singh, Thomas A. Cooper  Molecular Cell 
Volume 135, Issue 1, Pages (July 2008)
Base-Pairing between Untranslated Regions Facilitates Translation of Uncapped, Nonpolyadenylated Viral RNA  Liang Guo, Edwards M. Allen, W.Allen Miller 
Volume 3, Issue 1, Pages (January 1999)
Volume 12, Issue 4, Pages (October 2003)
Volume 11, Issue 3, Pages (March 2003)
Arginine Methylation of STAT1 Modulates IFNα/β-Induced Transcription
I-Cheng Ho, Martin R Hodge, John W Rooney, Laurie H Glimcher  Cell 
17β-estradiol, Progesterone, and Dihydrotestosterone Suppress the Growth of Human Melanoma by Inhibiting Interleukin-8 Production  Naoko Kanda, Shinichi.
Volume 37, Issue 1, Pages (January 2010)
Volume 4, Issue 6, Pages (December 1999)
Transcriptional Control of the Mouse Col7a1 Gene in Keratinocytes: Basal and Transforming Growth Factor-β Regulated Expression  Michael Naso, Jouni Uitto,
Gracjan Michlewski, Sonia Guil, Colin A. Semple, Javier F. Cáceres 
Ras Induces Mediator Complex Exchange on C/EBPβ
SUMO Promotes HDAC-Mediated Transcriptional Repression
Stefanie S. Schalm, Diane C. Fingar, David M. Sabatini, John Blenis 
Fabien Darfeuille, Cecilia Unoson, Jörg Vogel, E. Gerhart H. Wagner 
Zbigniew Dominski, Xiao-cui Yang, William F. Marzluff  Cell 
Stimulation of Type I Collagen Transcription in Human Skin Fibroblasts by TGF-β: Involvement of Smad 3  Shu-Jen Chen, Weihua Yuan, Yasuji Mori, Anait.
PARP1 Represses PAP and Inhibits Polyadenylation during Heat Shock
Volume 15, Issue 6, Pages (September 2004)
Volume 2, Issue 6, Pages (December 1998)
Transcriptional Regulation of ATP2C1 Gene by Sp1 and YY1 and Reduced Function of its Promoter in Hailey–Hailey Disease Keratinocytes  Hiroshi Kawada,
Role of the regulatory domain of the EGF-receptor cytoplasmic tail in selective binding of the clathrin-associated complex AP-2  Werner Boll, Andreas.
Naoko Kanda, Shinichi Watanabe  Journal of Investigative Dermatology 
Monica Kong-Beltran, Jennifer Stamos, Dineli Wickramasinghe 
Volume 118, Issue 1, Pages (July 2004)
Theodora Agalioti, Guoying Chen, Dimitris Thanos  Cell 
Volume 8, Issue 2, Pages (February 1998)
Halofuginone, an Inhibitor of Type-I Collagen Synthesis and Skin Sclerosis, Blocks Transforming-Growth-Factor-β-Mediated Smad3 Activation in Fibroblasts 
Volume 20, Issue 1, Pages (July 2017)
The Mammalian RNA Polymerase II C-Terminal Domain Interacts with RNA to Suppress Transcription-Coupled 3′ End Formation  Syuzo Kaneko, James L. Manley 
c-Src Activates Endonuclease-Mediated mRNA Decay
Volume 13, Issue 2, Pages (January 2004)
Phosphorylation on Thr-55 by TAF1 Mediates Degradation of p53
Volume 90, Issue 4, Pages (August 1997)
Volume 96, Issue 3, Pages (February 1999)
A Biochemical Function for the Sm Complex
Volume 96, Issue 6, Pages (March 1999)
tRNA Binds to Cytochrome c and Inhibits Caspase Activation
The Zipper Model of Translational Control
Cellular 5′-3′ mRNA Exonuclease Xrn1 Controls Double-Stranded RNA Accumulation and Anti-Viral Responses  Hannah M. Burgess, Ian Mohr  Cell Host & Microbe 
Richard W. Deibler, Marc W. Kirschner  Molecular Cell 
Two Functional Modes of a Nuclear Receptor-Recruited Arginine Methyltransferase in Transcriptional Activation  María J. Barrero, Sohail Malik  Molecular.
Exon Identity Established through Differential Antagonism between Exonic Splicing Silencer-Bound hnRNP A1 and Enhancer-Bound SR Proteins  Jun Zhu, Akila.
Volume 17, Issue 3, Pages (February 2005)
Functional Recognition of the 5′ Splice Site by U4/U6
TNF Regulates the In Vivo Occupancy of Both Distal and Proximal Regulatory Regions of the MCP-1/JE Gene  Dongsheng Ping, Peter L. Jones, Jeremy M. Boss 
Regulation of Yeast mRNA 3′ End Processing by Phosphorylation
Naoko Kanda, Shinichi Watanabe  Journal of Investigative Dermatology 
Frank S Lee, Jeremiah Hagler, Zhijian J Chen, Tom Maniatis  Cell 
Volume 73, Issue 6, Pages (March 2008)
Transcriptional Regulation by p53 through Intrinsic DNA/Chromatin Binding and Site- Directed Cofactor Recruitment  Joaquin M Espinosa, Beverly M Emerson 
Volume 4, Issue 4, Pages (October 1999)
Volume 17, Issue 3, Pages (March 2015)
Volume 7, Issue 6, Pages (June 2001)
Hepatocyte Growth Factor/Scatter Factor (HGF/SF) Induces Vascular Permeability Factor (VPF/VEGF) Expression by Cultured Keratinocytes  Jens Gille, Mona.
Functional Coupling of Capping and Transcription of mRNA
Phosphorylation of the pro-apoptotic protein BAD on serine 155, a novel site, contributes to cell survival  K. Virdee, P.A. Parone, A.M. Tolkovsky  Current.
Volume 3, Issue 1, Pages (January 1999)
Volume 90, Issue 2, Pages (July 1997)
Presentation transcript:

Volume 108, Issue 2, Pages 221-232 (January 2002) Human Interferon-γ mRNA Autoregulates Its Translation through a Pseudoknot that Activates the Interferon-Inducible Protein Kinase PKR  Yitzhak Ben-Asouli, Yona Banai, Yehuda Pel-Or, Alexei Shir, Raymond Kaempfer  Cell  Volume 108, Issue 2, Pages 221-232 (January 2002) DOI: 10.1016/S0092-8674(02)00616-5

Figure 1 Activation of PKR by IFN-γ mRNA and Binding of PKR and eIF2 (A) IFN-γ mRNA transcripts. Full-length 1264 nt, 469 nt, and 203 nt IFN-γ mRNA T7 transcripts (map) were generated as described in Experimental Procedures, resolved on a 1% agarose gel, and stained with ethidium bromide; M indicates denatured φx174/HincII DNA. (B–D) PKR activation. IFN-γ mRNA transcripts, dsRNA (polyI:polyC, Sigma), and TAR (77 nt; Ben-Asouli et al., 2000) were purified, and activation of PKR was assayed as described in Experimental Procedures. In (D) at bottom, 150 ng of purified eIF2 was added. Positions of PKR (68 kDa) and eIF2α (38 kDa) bands are shown. Binding of eIF2 (E) and PKR (F). Complex formation between uniformly 32P-labeled 203 nt RNA (0.08 pmol, 10,000 cpm) and eIF2 (0.1 pmol) or hPKR was analyzed as described in Experimental Procedures. In (E), binding was in the absence (−) or presence of 0.01, 0.05, 0.1, and 0.5 pmol of unlabeled RNA as indicated. Abbreviations are as follows: b, bound RNA; f, free; and c, control without eIF2 or PKR. Cell 2002 108, 221-232DOI: (10.1016/S0092-8674(02)00616-5)

Figure 2 Activation of PKR by 203 nt IFN-γ RNA (A–D) Activation of PKR by 203 nt RNA (203), antisense transcript (AS), or dsRNA at the indicated concentrations was assayed as described in Experimental Procedures. (A) 2-AP (Sigma) was present as shown. (B) RNA was assayed directly (−) or first digested for 15 min at 30°C with T1 RNase (1 U; Worthington) or V1 nuclease (0.1 U; Pharmacia). (D) RNA was assayed directly (−) or preincubated for 5 min at 95°C and cooled slowly in a water bath at room temperature (s) or fast in liquid nitrogen (f). (E) Activation of PKR and phosphorylation of eIF2α were assayed as indicated in the absence or presence of 0.5 ng/μl 203 nt RNA. After SDS-10% PAGE, duplicate samples were transferred to polyvinylidene difluoride membranes for Western blot analysis. Total PKR (lanes 3 and 4) and phosphorylated eIF2α (lanes 7 and 8) were determined as described in Experimental Procedures. The same membranes were used for autoradiography (lanes 1 and 2 and lanes 5 and 6, respectively). Cell 2002 108, 221-232DOI: (10.1016/S0092-8674(02)00616-5)

Figure 3 Effect of IFN-γ 5′ UTR Mutations on Activation of PKR and Binding of eIF2 (A) Activation of PKR was assayed as described in Experimental Procedures, with dsRNA, wt, or mutant form IFN-γ mRNA (map) as shown. (B and C) Complex formation between uniformly 32P-labeled 203 nt RNA (0.08 pmol, 10,000 cpm) and eIF2 (0.09 pmol) was assayed as described in Experimental Procedures, in the presence of unlabeled competitor IFN-γ mRNA in amounts shown in (C). Abbreviations are as follows: b, bound RNA; f, free; c, control without eIF2 (upper left lane). RNA bound in (B) was quantitated in (C) using NIH Image 1.61 software (wt, ▴; a4, ○; d1, ■; d2, •; d3, ▵; d4, □). Cell 2002 108, 221-232DOI: (10.1016/S0092-8674(02)00616-5)

Figure 4 Ability of IFN-γ mRNA to Activate PKR Regulates Its Translation in Vitro (A–C) wt and mutant IFN-γ mRNA transcripts were generated and purified, and 2 μg was translated in reticulocyte lysate as described in Experimental Procedures. In (A) and (B), intensity of the 35S-labeled IFN-γ band (top) was quantitated using NIH Image 1.61 software and plotted in arbitrary units (bottom). (A) Four independent experiments yielded, from left to right, mean IFN-γ values of 0 ± 0, 4.7 ± 2.7, 15.7 ± 2, 21.6 ± 2.1, 13 ± 2.5, 9.1 ± 1.8, and 8.6 ± 0.9 SEM. (B) wt and d1 mRNA were translated without or with 15 mM 2-AP. (C) d1 mRNA was translated with 203 nt RNA at the indicated concentrations. (D) Binding of PKR. Complex formation between uniformly 32P-labeled 203 nt RNA (0.08 pmol, 10,000 cpm) and bovine serum albumin (BSA)(1 μg) or hPKR (3.9 pmol) was analyzed as described in Experimental Procedures. Abbreviations are as follows: b, bound RNA; f, free; c, control without hPKR. Binding was in the absence (−) or presence of 0.001, 0.01, 0.1, and 1 pmol of unlabeled wt or d1 mRNA. Cell 2002 108, 221-232DOI: (10.1016/S0092-8674(02)00616-5)

Figure 5 Ability of IFN-γ mRNA to Activate PKR Regulates Its Translation in BHK-21 Cells (A) Translation efficiency. Cells were transfected as described in Experimental Procedures with 1 μg each of pSV2CAT and wt or mutant phIFN-γ-2 as indicated (− indicates transfected with 1 μg each of pSV2CAT and pBS; m indicates mock-transfected with 2 μg pBS); IFN-γ and CAT mRNA were quantitated by RNase protection analysis (top) and IFN-γ and CAT protein by ELISA. Relative translation efficiency is expressed as protein/mRNA ratio. Four independent experiments yielded, from left to right, IFN-γ/mRNA ratios of 5.0 ± 1.8, 39 ± 3.4, 58 ± 4.4, 30 ± 2.5, 15 ± 4.4, 22 ± 3.9, and 0 ± 0 and CAT/mRNA ratios of 45 ± 3.3, 56 ± 4, 49 ± 3, 59 ± 2.9, 58 ± 5.7, 54 ± 2.7, and 51 ± 1. (B) Phosphorylation of PKR. Cells were transfected with wt, d1, or a4 phIFN-γ-2 or with pBS; cells transfected with wt phIFN-γ-2 were also cultured with 15 mM 2-AP. Phosphorylated PKR (P-PKR) was determined as described in Experimental Procedures, using anti-PKR and anti-phospho-Ser antibodies (top); total PKR was determined by Western blot of the immunoprecipitate with antibody against N-terminal PKR peptide. Band intensity of P-PKR is plotted (bottom). Four independent experiments yielded, from left to right, values of 2.2 ± 0.5, 6.1 ± 1.1, 2.3 ± 1.0, 3.5 ± 0.2, and 0.7 ± 0.4. (C and D) Coexpression of PKRΔ6 or E3L. Cells were transfected as described in Experimental Procedures with wt, a4, or d1 phIFN-γ-2 and pBS (CTRL), pPKRΔ6, or pE3L, as indicated. IFN-γ mRNA and secreted IFN-γ were quantitated as in (A). IFN-γ protein/mRNA ratio is plotted in (C) and stimulation over CTRL in (D). A representative of four independent experiments is shown. (E) PKR−/− mouse fibroblasts were transfected with wt, a4, or d1 phIFN-γ-2 as in (A), except that amounts of DNA were doubled. IFN-γ and CAT mRNA were quantitated by RNase protection analysis and IFN-γ protein by high-sensitivity ELISA (Amersham Pharmacia). Cell 2002 108, 221-232DOI: (10.1016/S0092-8674(02)00616-5)

Figure 6 Nuclease Sensitivity Mapping of 203 nt RNA RNA (203 nt) (60 pmol) was 5′ end labeled, gel-purified, and partially digested with T1, U2, or V1 nucleases, and the cleavage products were resolved as described previously (Osman et al., 1999) by 8% sequencing PAGE; the gel was prerun at 1500 V to reach 50°C. Abbreviations are as follows: U, undigested RNA; G, G ladder obtained by digesting the RNA, denatured at 50°C in 7 M urea, with T1 (1 U); A, A ladder obtained by digesting the denatured RNA with U2 (1.5 U); and OH, alkaline hydrolysate. Size was calibrated using MspI-digested pGEM3 (not shown). Schematic at right shows sites and intensity of cuts summarized for seven independent experiments. Cell 2002 108, 221-232DOI: (10.1016/S0092-8674(02)00616-5)

Figure 7 Human IFN-γ mRNA Activates PKR and Regulates Its Translation through a Pseudoknot in the 5′ UTR (A) Activation of PKR by dsRNA, a4, or a3 203 nt RNA was assayed as described in Experimental Procedures. (B) Activation of PKR was assayed using wt or mutant 203 nt RNA or dsRNA (ds) (0.15 ng/μl). A representative of eight independent experiments is shown. Schematic on right shows part of the structure from Figure 6 with mutational changes in the pseudoknot stem. (C) Translation efficiency was assayed in transfected BHK-21 cells as for Figure 5A, using mutant constructs as indicated. IFN-γ and CAT mRNA were quantitated by RNase protection analysis (not shown), and IFN-γ and CAT protein by ELISA. Relative translation efficiency is expressed as protein/mRNA ratio. Autoradiogram shows newly synthesized actin, assayed after transfer of the cells to methionine-free medium (Biological Industries, Beit Haemek) for 4 hr, labeling for 4 hr with [35S]methionine (154 μCi/dish), immunoprecipitation of cell lysate with 6 μg of antibody against 43 kDa actin (Santa Cruz) and SDS-10% PAGE; film intensity is plotted in arbitrary units. (D) Total and phosphorylated PKR and eIF2α were assayed in cell lysates from (C), as described in Experimental Procedures. (E) Translation efficiency was assayed as in (C), except that peIF2αS51A (Fernandez et al., 2002) was cotransfected. IFN-γ and CAT mRNA were quantitated by RNase protection analysis (not shown) and IFN-γ protein by ELISA. m indicates mock-transfected with 2 μg pBS. A representative of three independent experiments is shown. Cell 2002 108, 221-232DOI: (10.1016/S0092-8674(02)00616-5)